C
Closed Loop Medicine
Closed Loop Medicine is a TechBio company developing prescription combination drug + software products
About Closed Loop Medicine
Closed Loop Medicine operates as a TechBio company focused on developing combination prescription products that pair drug therapy with digital software. Founded in 2017 by Dr. Hakim Yadi OBE, Dr. Paul Goldsmith, Dr. David Cox, and Dr. Felicity Sartain, the Cambridge-based firm aims to advance personalized medicine. The company's core business revolves around a proprietary platform that creates regulated, single-prescription products designed to optimize medication dosage in real-time. This is achieved by integrating data from medical devices, wearables, and patient-led digital experiences to create closed-loop models of care that adjust treatment for individuals.
The founding team brings together deep expertise in science, medicine, and technology. Dr. Hakim Yadi, the founding CEO, has a PhD in Immunology and extensive experience in the life sciences investment sector and government health policy. Co-founder Dr. Paul Goldsmith is a consultant neurologist with a PhD in developmental biology and a history of founding several healthcare businesses, including DanioLabs. This blend of clinical and commercial experience underpins the company's strategy. Since its inception, Closed Loop Medicine has raised over £22 million (c. $30 million) from investors such as Ananda Impact Ventures, BGF, and IQ Capital, enabling the development of its product pipeline.
The company's business model targets pharmaceutical companies, payers, and healthcare providers by creating patent-protected combination products that can enhance established medicines. By developing a software layer that accompanies a drug, Closed Loop Medicine aims to improve treatment efficacy, reduce side effects, and increase patient adherence, thereby lowering overall healthcare costs. The platform's initial focus areas include chronic conditions like hypertension and insomnia, with a broader pipeline of over 30 potential combination products. A recent partnership with Pharmanovia, for example, focuses on combining an anti-hypertensive drug with Closed Loop's Software-as-a-Medical-Device (SaMD) to offer personalized dosing. This approach allows the company to create new value for existing, trusted medications by turning them into precision medicine solutions.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2017
- Headquarters
- Sawston, United Kingdom
- Employees
- 7
- Open positions
- None listed
- Dealroom signal
- 58.7/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Biotechnology, Precision Medicine, Digital Therapeutics, Tech for Patients, BIA Techbio UK, Techbio, Hard Tech, Woman Founder, Techbio Drug Discovery
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| GRANT✓Other financing | Feb 2023 | — | — | Undisclosed | — |
| SERIES A✓Equity / VC | Nov 2021 | $17M | $69M | Downing Ventures · LifeArc · Longwall · Meltwind | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for Closed Loop Medicine is 1.3K monthly website visits, up 0% over the last three months. Closed Loop Medicine's team declined 73.1% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed4 investors entered at this stage
Cambridge Angels
Longwall Ventures
Martlet
IQ Capital
Series A6 investors entered at this stage
Business Growth Fund
Ananda Impact Ventures
Downing Ventures
LifeArc
Longwall
Meltwind
Other known investors2 additional known investors
- HEhealthtech.vc
LifeArc Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Closed Loop Medicine on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Closed Loop Medicine’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.